Genmab A/S (GMAB) M&A Name Transcript

Operator

Good day to Genmab’s convention name relating to its proposed acquisition of Merus. As a reminder, this convention name is being recorded. Throughout this phone convention, you could be offered with forward-looking statements that embody phrases comparable to believes, anticipates, plans or expects. Precise outcomes might differ materially, for instance, because of delayed or unsuccessful improvement tasks.

Genmab shouldn’t be underneath any obligation to replace statements relating to the long run, nor to verify such statements in relation to precise outcomes, until that is required by regulation. Please additionally notice that Genmab might maintain your private information as indicated by you as a part of our Investor Relations outreach actions, to be able to replace you on Genmab going ahead. Please check with our web site for extra info on Genmab and our privateness coverage. I’d now like handy the convention over to your first speaker right this moment, Jan van de Winkel. Please go forward.

Jan van de Winkel
Co-Founder, President & CEO

Good day, and thanks for becoming a member of us. Immediately, we’re sharing a transformative step for Genmab, our deliberate acquisition of Merus. With me right this moment to current this thrilling information is our Chief Medical Officer, Tahi Ahmadi, who